1898P A phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma: JME-001.
Saved in:
| Title: | 1898P A phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma: JME-001. |
|---|---|
| Authors: | Fujimoto, N.1 (AUTHOR), Kozuki, T.2 (AUTHOR), Aoe, K.3 (AUTHOR), Miyamoto, Y.4 (AUTHOR), Wada, S.4 (AUTHOR), Harada, D.2 (AUTHOR), Yoshida, M.5 (AUTHOR), Sakurai, J.5 (AUTHOR), Hotta, K.5 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS1077-S1077. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152695971 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1898P A phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma: JME-001. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Fujimoto%2C+N%2E%22">Fujimoto, N.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kozuki%2C+T%2E%22">Kozuki, T.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aoe%2C+K%2E%22">Aoe, K.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Miyamoto%2C+Y%2E%22">Miyamoto, Y.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wada%2C+S%2E%22">Wada, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Harada%2C+D%2E%22">Harada, D.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yoshida%2C+M%2E%22">Yoshida, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sakurai%2C+J%2E%22">Sakurai, J.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hotta%2C+K%2E%22">Hotta, K.</searchLink><relatesTo>5</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 4, Vol. 31, pS1077-S1077. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152695971 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2020.08.1441 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S1077 Titles: – TitleFull: 1898P A phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma: JME-001. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fujimoto, N. – PersonEntity: Name: NameFull: Kozuki, T. – PersonEntity: Name: NameFull: Aoe, K. – PersonEntity: Name: NameFull: Miyamoto, Y. – PersonEntity: Name: NameFull: Wada, S. – PersonEntity: Name: NameFull: Harada, D. – PersonEntity: Name: NameFull: Yoshida, M. – PersonEntity: Name: NameFull: Sakurai, J. – PersonEntity: Name: NameFull: Hotta, K. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2020 Supplement 4 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 31 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
